Tyra Biosciences (TYRA) Payables (2020 - 2026)

Quarterly Payables rose 45.68% to $3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Mar 2026, up 45.68% year-over-year, with the annual reading at $1.2 million for FY2025, 99.66% up from the prior year.

Tyra Biosciences filings provide 7 years of Payables readings, the most recent being $3.6 million for Q1 2026.

  • Payables hit $3.6 million in Q1 2026 for Tyra Biosciences, up from $1.2 million in the prior quarter.
  • Across five years, Payables topped out at $4.7 million in Q4 2023 and bottomed at $590000.0 in Q4 2024.
  • Average Payables over 5 years is $2.1 million, with a median of $2.0 million recorded in 2025.
  • The largest annual shift saw Payables surged 307.16% in 2023 before it tumbled 87.34% in 2024.
  • Tyra Biosciences' Payables stood at $1.1 million in 2022, then soared by 307.16% to $4.7 million in 2023, then tumbled by 87.34% to $590000.0 in 2024, then surged by 99.66% to $1.2 million in 2025, then skyrocketed by 209.17% to $3.6 million in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Payables are $3.6 million (Q1 2026), $1.2 million (Q4 2025), and $2.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 300,549.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.05 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 10.62 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 8.69 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 489.30 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.03 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 126.63 Mn
10 Tyra Biosciences 2.03 Bn 2.03 Bn - 3.64 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.64 Mn
Dec 31, 2025 1.18 Mn
Sep 30, 2025 1.99 Mn
Jun 30, 2025 2.25 Mn
Mar 31, 2025 2.50 Mn
Dec 31, 2024 590,000.00
Sep 30, 2024 1.17 Mn
Jun 30, 2024 1.58 Mn
Mar 31, 2024 2.88 Mn
Dec 31, 2023 4.66 Mn
Sep 30, 2023 2.31 Mn
Jun 30, 2023 1.44 Mn
Mar 31, 2023 1.28 Mn
Dec 31, 2022 1.15 Mn
Sep 30, 2022 2.75 Mn
Jun 30, 2022 2.34 Mn
Mar 31, 2022 1.36 Mn
Dec 31, 2021 599,000.00
Sep 30, 2021 2.07 Mn
Dec 31, 2020 664,000.00